Responses
Oncolytic and local immunotherapy
Original research
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.